Metabolic syndrome reduces the contribution of K+ channels to ischemic coronary vasodilation

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 298, Issue 4, 2010, Pages

  Borbouse, Léna ^a   Dick, Gregory M ^b   Payne, Gregory A ^a   Berwick, Zachary C ^a   Neeb, Zachary P ^a   Alloosh, Mouhamad ^a   Bratz, Ian N ^c   Sturek, Michael ^a   Tune, Johnathan D ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Northeast Ohio Medical University   (United States)

Author keywords

Adenosine triphosphate dependent potassium channels; Calcium activated potassium channels; Coronary reactive hyperemia; Ossabaw miniature swine; Type 2 diabetes; Voltage activated potassium channels

Indexed keywords

4 AMINOPYRIDINE; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; FAT; FRUCTOSE; GLIBENCLAMIDE; GLUCOSE; PENITREM A; POTASSIUM CHANNEL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENIC DIET; BODY WEIGHT; CALORIC INTAKE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; HUMAN; HYPEREMIA; METABOLIC SYNDROME X; NONHUMAN; PRIORITY JOURNAL; SWINE; VASODILATATION;

ANIMALS; BLOOD PRESSURE; CORONARY VESSELS; DISEASE MODELS, ANIMAL; FEMALE; HYPEREMIA; KATP CHANNELS; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNEL ALPHA SUBUNITS; MALE; METABOLIC SYNDROME X; MYOCARDIAL ISCHEMIA; POTASSIUM CHANNELS; POTASSIUM CHANNELS, VOLTAGE-GATED; REGIONAL BLOOD FLOW; SWINE; VASODILATION;

EID: 77949735233     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00888.2009     Document Type: Article

References (50)

1. Acree LS, Comp PC, Whitsett TL, Montgomery PS, Nickel KJ, Fjeldstad AS, Fjeldstad C, Gardner AW. The influence of obesity on calf blood flow and vascular reactivity in older adults (Abstract). Dyn Med 6: 4, 2007.
2. Banitt PF, Smits P, Williams SB, Ganz P, Creager MA. Activation of ATP-sensitive potassium channels contributes to reactive hyperemia in humans. Am J Physiol Heart Circ Physiol 271: H1594-H1598, 1996.
3. Bender SB, Tune JD, Borbouse L, Long X, Sturek M, Laughlin MH. Altered mechanism of adenosine-induced coronary arteriolar dilation in early-stage metabolic syndrome. Exp Biol Med (Maywood) 234: 683-692, 2009.
4. Ca channels in metabolic syndrome. Am J Physiol Heart Circ Physiol 297: H1629-H1637, 2009.
5. Ca channels to local metabolic coronary vasodilation: effects of metabolic syndrome. Am J Physiol Heart Circ Physiol. doi:10.1152/ajpheart.00876.2009.
6. Bratz IN, Dick GM, Tune JD, Edwards JM, Neeb ZP, Dincer UD, Sturek M. Impaired capsaicin-induced relaxation of coronary arteries in a porcine model of the metabolic syndrome. Am J Physiol Heart Circ Physiol 294: H2489-H2496, 2008.
7. + channels from arteries of type 2 diabetic Zucker diabetic fatty rats. Am J Physiol Heart Circ Physiol 290: H1520-H1527, 2006.
8. Camici PG, Marraccini P, Lorenzoni R, Buzzigoli G, Pecori N, Perissinotto A, Ferrannini E, L'Abbate A, Marzilli M. Coronary hemodynamics and myocardial metabolism in patients with syndrome X: response to pacing stress. J Am Coll Cardiol 17: 1461-1470, 1991.
9. Capecchi PL, Guideri F, Colafati M, Acampa M, Cuomo A, Lazzerini PE, Pasini FL. Acute effects of glibenclamide on reactive hyperaemia in the lower limbs in humans. Clin Hemorheol Microcirc 27: 77-82, 2002.
10. Dagres N, Saller B, Haude M, Husing J, von BC, Schmermund A, Sack S, Baumgart D, Mann K, Erbel R. Insulin sensitivity and coronary vasoreactivity: insulin sensitivity relates to adenosine-stimulated coronary flow response in human subjects. Clin Endocrinol (Oxf) 61: 724-731, 2004.
11. De FE, Cusi K, Ocampo G, Berria R, Buck S, Consoli A, Mandarino LJ. Exercise-induced improvement in vasodilatory function accompanies increased insulin sensitivity in obesity and type 2 diabetes mellitus. J Clin Endocrinol Metab 91: 4903-4910, 2006.
12. + channels regulate the duration of reactive hyperemia in the canine coronary circulation. Am J Physiol Heart Circ Physiol 294: H2371-H2381, 2008.
13. Ca) currents are reduced in microvascular smooth muscle cells from insulin-resistant rats. Am J Physiol Heart Circ Physiol 282: H908-H917, 2002.
14. Dincer UD, Araiza AG, Knudson JD, Molina PE, Tune JD. Sensitization of coronary alpha-adrenoceptor vasoconstriction in the prediabetic metabolic syndrome. Microcirculation 13: 587-595, 2006.
15. Duncker DJ, van Zon NS, Altman JD, Pavek TJ, Bache RJ. Role of K+ATP channels in coronary vasodilation during exercise. Circulation 88: 1245-1253, 1993.
16. Duncker DJ, van Zon NS, Ishibashi Y, Bache RJ. Role of K+ ATP channels and adenosine in the regulation of coronary blood flow during exercise with normal and restricted coronary blood flow. J Clin Invest 97: 996-1009, 1996.
17. Dyson MC, Alloosh M, Vuchetich JP, Mokelke EA, Sturek M. Components of metabolic syndrome and coronary artery disease in female Ossabaw swine fed excess atherogenic diet. Comp Med 56: 35-45, 2006.
18. Edwards JM, Alloosh MA, Long XL, Dick GM, Lloyd PG, Mokelke EA, Sturek M. Adenosine A1 receptors in neointimal hyperplasia and in-stent stenosis in Ossabaw miniature swine. Coron Artery Dis 19: 27-31, 2008.
19. Feigl EO, Neat GW, Huang AH. Interrelations between coronary artery pressure, myocardial metabolism and coronary blood flow. J Mol Cell Cardiol 22: 375-390, 1990.
20. Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med 119: 812-819, 2006.
21. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, Mitch W, Smith SC Jr, Sowers JR. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 100: 1134-1146, 1999.
22. Heaps CL, Jeffery EC, Laine GA, Price EM, Bowles DK. Effects of exercise training and hypercholesterolemia on adenosine activation of voltage-dependent K+ channels in coronary arterioles. J Appl Physiol 105: 1761-1771, 2008.
23. Heaps CL, Tharp DL, Bowles DK. Hypercholesterolemia abolishes voltage-dependent K+ channel contribution to adenosine-mediated relaxation in porcine coronary arterioles. Am J Physiol Heart Circ Physiol 288: H568-H576, 2005.
24. Henry P, Thomas F, Benetos A, Guize L. Impaired fasting glucose, blood pressure and cardiovascular disease mortality. Hypertension 40: 458-463, 2002.
25. Hodnett BL, Xiang L, Dearman JA, Carter CB, Hester RL. K(ATP)-mediated vasodilation is impaired in obese Zucker rats. Microcirculation 15: 485-494, 2008.
26. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 67: 968-977, 1983.
27. Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 110: 1251-1257, 2004.
28. Ishibashi Y, Duncker DJ, Zhang J, Bache RJ. ATP-sensitive K+ channels, adenosine, and nitric oxide-mediated mechanisms account for coronary vasodilation during exercise. Circ Res 82: 346-359, 1998.
29. Ishibashi Y, Takahashi N, Shimada T, Sugamori T, Sakane T, Umeno T, Hirano Y, Oyake N, Murakami Y. Short duration of reactive hyperemia in the forearm of subjects with multiple cardiovascular risk factors. Circ J 70: 115-123, 2006.
30. Jackson WF. Ion channels and vascular tone. Hypertension 35: 173-178, 2000.
31. Kiviniemi TO, Snapir A, Saraste M, Toikka JO, Raitakari OT, Ahotupa M, Hartiala JJ, Scheinin M, Koskenvuo JW. Determinants of coronary flow velocity reserve in healthy young men. Am J Physiol Heart Circ Physiol 291: H564-H569, 2006.
32. Knudson JD, Rogers PA, Dincer UD, Bratz IN, Araiza AG, Dick GM, Tune JD. Coronary vasomotor reactivity to endothelin-1 in the prediabetic metabolic syndrome. Microcirculation 13: 209-218, 2006.
33. Kondo I, Mizushige K, Hirao K, Nozaki S, Tsuji T, Masugata H, Kohno M, Matsuo H. Ultrasonographic assessment of coronary flow reserve and abdominal fat in obesity. Ultrasound Med Biol 27: 1199-1205, 2001.
34. ATP channels in endothelium. Am J Physiol Heart Circ Physiol 269: H541-H549, 1995.
35. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. J Am Med Assoc 288: 2709-2716, 2002.
36. Li H, Chai Q, Gutterman DD, Liu Y. Elevated glucose impairs cAMP-mediated dilation by reducing Kv channel activity in rat small coronary smooth muscle cells. Am J Physiol Heart Circ Physiol 285: H1213-H1219, 2003.
37. Liu Y, Terata K, Rusch NJ, Gutterman DD. High glucose impairs voltage-gated K(+) channel current in rat small coronary arteries. Circ Res 89: 146-152, 2001.
38. Miura H, Liu Y, Gutterman DD. Human coronary arteriolar dilation to bradykinin depends on membrane hyperpolarization: contribution of nitric oxide and Ca2+-activated K+ channels. Circulation 99: 3132-3138, 1999.
39. Miura H, Wachtel RE, Loberiza FR Jr, Saito T, Miura M, Nicolosi AC, Gutterman DD. Diabetes mellitus impairs vasodilation to hypoxia in human coronary arterioles: reduced activity of ATP-sensitive potassium channels. Circ Res 92: 151-158, 2003.
40. Mokelke EA, Dietz NJ, Eckman DM, Nelson MT, Sturek M. Diabetic dyslipidemia and exercise affect coronary tone and differential regulation of conduit and microvessel K+ current. Am J Physiol Heart Circ Physiol 288: H1233-H1241, 2005.
41. Nelson MT, Patlak JB, Worley JF, Standen NB. Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone. Am J Physiol Cell Physiol 259: C3-C18, 1990.
42. Node K, Kitakaze M, Kosaka H, Minamino T, Hori M. Bradykinin mediation of Ca(2+)-activated K+ channels regulates coronary blood flow in ischemic myocardium. Circulation 95: 1560-1567, 1997.
43. Olsson RA. Myocardial reactive hyperemia. Circ Res 37: 263-270, 1975.
44. Ritchie SA, Connell JM. The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis 17: 319-326, 2007.
45. Ruiter JH, Spaan JA, Laird JD. Transient oxygen uptake during myocardial reactive hyperemia in the dog. Am J Physiol Heart Circ Physiol 235: H87-H94, 1978.
46. Schindler TH, Cardenas J, Prior JO, Facta AD, Kreissl MC, Zhang XL, Sayre J, Dahlbom M, Licinio J, Schelbert HR. Relationship between increasing body weight, insulin resistance, inflammation, adipocytokine leptin, and coronary circulatory function. J Am Coll Cardiol 47: 1188-1195, 2006.
47. Setty S, Sun W, Tune JD. Coronary blood flow regulation in the prediabetic metabolic syndrome. Basic Res Cardiol 98: 416-423, 2003.
48. Sturek M, Alloosh M, Wenzel J, Byrd JP, Edwards JM, Lloyd PG, Tune JD, March KL, Miller MA, Mokelke EA, Brisbin IL. Ossabaw island miniature swine: cardiometabolic syndrome assessment. In: Swine in the Laboratory: Surgery, Anesthesia, Imaging and Experimental Techniques , edited by Swindle MM. Boca Raton, FL: CRC, 2007, p. 397-402.
49. Zatta AJ, Headrick JP. Mediators of coronary reactive hyperaemia in isolated mouse heart. Br J Pharmacol 144: 576-587, 2005.
50. 1 receptors. Am J Physiol Heart Circ Physiol 288: H2154-H2162, 2005.